MARBURG, Germany, July 04, 2024 (GLOBE NEWSWIRE) -- Global biotechnology leader CSL Behring (ASX: CSL) today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (......
VALENCIA, Spain and BRUSSELS, July 03, 2024 (GLOBE NEWSWIRE) -- Seeking alternatives to obtain oocytes without ovarian stimulation is a pioneering line of research in reproductive medicine. The inconv......
NEW YORK, July 03, 2024 (GLOBE NEWSWIRE) -- CertiK, the industry leader in blockchain security, today announced the release of its latest publication. Hack3d: The Web3 Security Report for Q2 and H1 20......
